Carregando...
Oncolytic virus-mediated targeting of PGE(2) in the tumor alters the immune status and sensitizes established and resistant tumors to immunotherapy
Immunotherapies are highly promising cancer treatments, but understanding the factors mediating their resistance remains critical. Successes in randomized clinical testing have supported the growing appreciation that oncolytic virotherapies primarily act as immunotherapies. Here we identified prosta...
Na minha lista:
| Publicado no: | Cancer Cell |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4962335/ https://ncbi.nlm.nih.gov/pubmed/27374223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2016.05.012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|